Course Overview

This two-part on-demand webcast series will change the way you diagnose and manage Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD). MASLD is the most common cause of chronic liver disease worldwide and growing in prevalence, but as many as half of patients may be undiagnosed. MASLD is hidden in plain sight.

In this session recorded at ObesityWeek® 2025, you’ll meet a patient and walk through their diagnosis and treatment. You’ll discover:

  • The surprising prevalence of MASLD
  • Accurate testing methods and which patients to screen
  • Therapeutic targets that have the biggest impact
  • Emerging treatments that could change the landscape
Jaime P. Almandoz
Jaime P. Almandoz, MD, MBA, FTOS, DABOM

Medical Director, Weight Loss Wellness Program
UT Southwestern Medical Center
Dallas, TX


Lee Kaplan
Lee Kaplan, MD, PhD, FTOS​

Professor of Medicine and Chief,
Section of Obesity Medicine​
Geisel School of Medicine,
Dartmouth